5-fluorodopamine has been researched along with Multiple System Atrophy Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV | 1 |
| Goldstein, DS | 1 |
1 review(s) available for 5-fluorodopamine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
1 other study(ies) available for 5-fluorodopamine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Cardiac sympathetic denervation in Parkinson disease.
Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver | 2000 |